What is the most recent earnings date for CTSO stock?
CYTOSORBENTS CORP (CTSO) last reported earnings on 1/2/2026.
CYTOSORBENTS CORP (CTSO) Earnings History & Surprises
NASDAQ:CTSO • US23283X2062
Current stock price
0.66 USD
+0.02 (+3.45%)
At close:
0.6599 USD
0 (-0.02%)
Pre-Market:
CTSO Earnings overview
Past quarterly earnings results for CYTOSORBENTS CORP (CTSO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 25, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.05
- Revenue Estimate
- 9.778M
Last Reported
Most Recent- Release Date
- Jan 2, 2026
- Period
- Q3 / 2025
- EPS Reported
- -$0.05
- EPS Surprise
- -5.03%
- Revenue Surprise
- -7.32%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.05 | -0.05 | -5.03% | -25.00% | 9.485M | 10.234M | -7.32% | 1.01% |
| Q2 2025 | 0.03 | -0.05 | 158.82% | 137.50% | 9.617M | 9.419M | 2.10% | -2.81% |
| Q1 2025 | -0.02 | -0.07 | 71.99% | 83.33% | 8.727M | 9.187M | -5.01% | -10.82% |
| Q4 2024 | -0.14 | -0.06 | -116.73% | -7.69% | 9.15M | 10.302M | -11.18% | 5.56% |
| Q3 2024 | -0.04 | -0.06 | 38.08% | 80.95% | 9.39M | 10.385M | -9.58% | 6.58% |
| Q2 2024 | -0.08 | -0.10 | 19.56% | 42.86% | 9.895M | 9.871M | 0.24% | 5.03% |
| Q1 2024 | -0.12 | -0.12 | 1.96% | 29.41% | 9.786M | 9.98M | -1.94% | 3.56% |
| Q4 2023 | -0.13 | -0.14 | 7.31% | -550.00% | 8.668M | 9.471M | -8.48% | -7.69% |
| Q3 2023 | -0.21 | -0.14 | -49.19% | 25.00% | 8.811M | 9.461M | -6.87% | 8.64% |
| Q2 2023 | -0.14 | -0.11 | -22.00% | 44.00% | 9.421M | 11.247M | -16.24% | 10.83% |
| Q1 2023 | -0.17 | -0.13 | -31.58% | 19.05% | 9.45M | 8.908M | 6.08% | 8.74% |
| Q4 2022 | -0.02 | -0.17 | 88.33% | 90.48% | 9.39M | 8.899M | 5.52% | -12.89% |
| Q3 2022 | -0.28 | -0.17 | -67.38% | -86.67% | 8.11M | 9.159M | -11.45% | -16.91% |
| Q2 2022 | -0.25 | -0.14 | -83.25% | -127.27% | 8.5M | 9.767M | -12.97% | -29.28% |
| Q1 2022 | -0.21 | -0.12 | -68.07% | -110.00% | 8.69M | 9.922M | -12.42% | -18.02% |
| Q4 2021 | -0.21 | -0.14 | -55.50% | - | 10.78M | 10.309M | 4.57% | -9.87% |
| Q3 2021 | -0.15 | -0.12 | -20.87% | -650.00% | 9.76M | 11.243M | -13.19% | -7.49% |
| Q2 2021 | -0.11 | -0.04 | -175.53% | -37.50% | 12.02M | 12.514M | -3.95% | 22.78% |
| Q1 2021 | -0.10 | -0.03 | -194.15% | - | 10.6M | 11.734M | -9.66% | 21.70% |
| Q4 2020 | 0.00 | -0.04 | 100.00% | - | 11.96M | 11.166M | 7.11% | - |
| Q3 2020 | -0.02 | -0.09 | 78.33% | - | 10.55M | 9.705M | 8.71% | - |
| Q2 2020 | -0.08 | -0.08 | -0.13% | - | 9.79M | 9.781M | 0.09% | - |
| Q1 2020 | -0.10 | -0.14 | 27.38% | - | 8.71M | 7.145M | 21.90% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
27.26%
Max EPS beat (4)
158.82%
Min EPS beat (4)
-116.73%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-5.35%
Max Revenue beat (4)
2.10%
Min Revenue beat (4)
-11.18%
Analysis
In the last 4 quarters, CTSO has beaten EPS estimates in 2 out of 4 releases
CTSO has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, CTSO has beaten the EPS estimates by 27.3% on average.
In the last 4 quarters, CTSO reported -5.4% below the revenue estimates on average.
Related analysis
CYTOSORBENTS CORP / CTSO Earnings FAQ
Did CYTOSORBENTS CORP (CTSO) beat earnings estimates last quarter?
CYTOSORBENTS CORP (CTSO) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does CYTOSORBENTS CORP (CTSO) beat earnings estimates?
In the last 4 quarters, CYTOSORBENTS CORP (CTSO) has beaten EPS estimates in 2 out of 4 releases.